Seibyl J - Search Results

1

Diffusion imaging of nigral alterations in early Parkinson's disease with dopaminergic deficits.

Schuff N, Wu IW, Buckley S, Foster ED, Coffey CS, Gitelman DR, Mendick S, Seibyl J, Simuni T, Zhang Y, Jankovic J, Hunter C, Tanner CM, Rees L, Factor S, Berg D, Wurster I, Gauss K, Sprenger F, Seppi K, Poewe W, Mollenhauer B, Knake S, Mari Z, McCoy A, Ranola M, Marek K. Schuff N, et al. Among authors: seibyl j. Mov Disord. 2015 Dec;30(14):1885-92. doi: 10.1002/mds.26325. Epub 2015 Aug 11. Mov Disord. 2015. PMID: 26260437

2

Decreased single-photon emission computed tomographic [123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson's disease.

Seibyl JP, Marek KL, Quinlan D, Sheff K, Zoghbi S, Zea-Ponce Y, Baldwin RM, Fussell B, Smith EO, Charney DS, van Dyck C, et al. Seibyl JP, et al. Ann Neurol. 1995 Oct;38(4):589-98. doi: 10.1002/ana.410380407. Ann Neurol. 1995. PMID: 7574455

3

[123I] beta-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease.

Marek KL, Seibyl JP, Zoghbi SS, Zea-Ponce Y, Baldwin RM, Fussell B, Charney DS, van Dyck C, Hoffer PB, Innis RP. Marek KL, et al. Among authors: seibyl jp. Neurology. 1996 Jan;46(1):231-7. doi: 10.1212/wnl.46.1.231. Neurology. 1996. PMID: 8559382

4

Images in neuroscience. Neuroimaging, XII. SPECT imaging of dopamine nerve terminals.

Seibyl JP, Marek K, Innis RB. Seibyl JP, et al. Am J Psychiatry. 1996 Sep;153(9):1131. doi: 10.1176/ajp.153.9.1131. Am J Psychiatry. 1996. PMID: 8780413 No abstract available.

5

Test/retest reproducibility of iodine-123-betaCIT SPECT brain measurement of dopamine transporters in Parkinson's patients.

Seibyl JP, Marek K, Sheff K, Baldwin RM, Zoghbi S, Zea-Ponce Y, Charney DS, van Dyck CH, Hoffer PB, Innis RB. Seibyl JP, et al. J Nucl Med. 1997 Sep;38(9):1453-9. J Nucl Med. 1997. PMID: 9293807 Free article.

6

Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.

Seibyl JP, Marek K, Sheff K, Zoghbi S, Baldwin RM, Charney DS, van Dyck CH, Innis RB. Seibyl JP, et al. J Nucl Med. 1998 Sep;39(9):1500-8. J Nucl Med. 1998. PMID: 9744331 Free article.

7

Effect of treatment with L-dopa/carbidopa or L-selegiline on striatal dopamine transporter SPECT imaging with [123I]beta-CIT.

Innis RB, Marek KL, Sheff K, Zoghbi S, Castronuovo J, Feigin A, Seibyl JP. Innis RB, et al. Among authors: seibyl jp. Mov Disord. 1999 May;14(3):436-42. doi: 10.1002/1531-8257(199905)14:3<436::aid-mds1008>3.0.co;2-j. Mov Disord. 1999. PMID: 10348466 Clinical Trial.

8

TechSight. Imaging. A molecular map for neurodegeneration.

Marek K, Seibyl J. Marek K, et al. Among authors: seibyl j. Science. 2000 Jul 21;289(5478):409-11. doi: 10.1126/science.289.5478.409. Science. 2000. PMID: 10939953 No abstract available.

9

Hemi-parkinsonism due to a midbrain arteriovenous malformation: dopamine transporter imaging.

Goldstein S, Friedman JH, Innis R, Seibyl J, Marek K. Goldstein S, et al. Among authors: seibyl j. Mov Disord. 2001 Mar;16(2):350-3. doi: 10.1002/mds.1047. Mov Disord. 2001. PMID: 11295793 No abstract available.

10

[123I]beta-CIT SPECT imaging assessment of the rate of Parkinson's disease progression.

Marek K, Innis R, van Dyck C, Fussell B, Early M, Eberly S, Oakes D, Seibyl J. Marek K, et al. Among authors: seibyl j. Neurology. 2001 Dec 11;57(11):2089-94. doi: 10.1212/wnl.57.11.2089. Neurology. 2001. PMID: 11739831

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

316 results

Search Page

Filters